trimethoprim has been researched along with Agnosia for Faces in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with trimethoprim resulted in a significant increase in plasma potassium concentration (4." | 1.31 | The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects. ( Don, BR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Don, BR | 1 |
1 other study available for trimethoprim and Agnosia for Faces
| Article | Year |
|---|---|
The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects.
Topics: Adult; Anti-Infective Agents; Humans; Middle Aged; Potassium; Prosopagnosia; Reference Values; Trime | 2001 |